Pleomorphic Liposarcoma Revisited.
Hadjimichael AC, Bekos A, Tsukamoto S, Nitta Y, Righi A, Errani C, Mavrogenis AF.
Orthopedics. 2023 Mar-Apr;46(2):e72-e80. doi: 10.3928/01477447-20220719-05. Epub 2022 Jul 25.
Myxoid pleomorphic liposarcoma.
Fadaei S, Cordier F, Ferdinande L, Van Dorpe J, Creytens D.
Histol Histopathol. 2024 Sep;39(9):1101-1108. doi: 10.14670/HH-18-724. Epub 2024 Feb 26.
Myxoid Pleomorphic Liposarcoma.
Dermawan JK.
Surg Pathol Clin. 2024 Mar;17(1):25-29. doi: 10.1016/j.path.2023.06.005. Epub 2023 Aug 1.
Pleomorphic liposarcoma: Updates and current differential diagnosis.
Anderson WJ, Jo VY.
Semin Diagn Pathol. 2019 Mar;36(2):122-128. doi: 10.1053/j.semdp.2019.02.007. Epub 2019 Feb 28.
Clinical and Molecular Spectrum of Liposarcoma.
Lee ATJ, Thway K, Huang PH, Jones RL.
J Clin Oncol. 2018 Jan 10;36(2):151-159. doi: 10.1200/JCO.2017.74.9598. Epub 2017 Dec 8.
Pleomorphic liposarcoma.
Oliveira AM, Nascimento AG.
Semin Diagn Pathol. 2001 Nov;18(4):274-85.
Liposarcoma: Multimodality Management and Future Targeted Therapies.
Crago AM, Dickson MA.
Surg Oncol Clin N Am. 2016 Oct;25(4):761-73. doi: 10.1016/j.soc.2016.05.007. Epub 2016 Jul 30.
Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K.
Semin Diagn Pathol. 2019 Mar;36(2):112-121. doi: 10.1053/j.semdp.2019.02.006. Epub 2019 Feb 28.
Pleomorphic Liposarcoma Unraveled: Investigating Histopathological and Immunohistochemical Markers for Tailored Diagnosis and Therapeutic Innovations.
Ciongariu AM, Țăpoi DA, Dumitru AV, Bejenariu A, Marin A, Costache M.
Medicina (Kaunas). 2024 Jun 7;60(6):950. doi: 10.3390/medicina60060950.
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.
Assi T, Ngo C, Faron M, Verret B, Lévy A, Honoré C, Hénon C, Le Péchoux C, Bahleda R, Le Cesne A.
Curr Treat Options Oncol. 2023 Nov;24(11):1598-1613. doi: 10.1007/s11864-023-01139-3. Epub 2023 Oct 16.
